The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.968C>G (p.Thr323Arg)

CA320251671

2076125 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 735a8cdc-ae26-4fbf-b706-49da306cefca
Approved on: 2024-07-25
Published on: 2024-07-25

HGVS expressions

NM_001754.5:c.968C>G
NM_001754.5(RUNX1):c.968C>G (p.Thr323Arg)
NC_000021.9:g.34792610G>C
CM000683.2:g.34792610G>C
NC_000021.8:g.36164907G>C
CM000683.1:g.36164907G>C
NC_000021.7:g.35086777G>C
NG_011402.2:g.1197102C>G
ENST00000675419.1:c.968C>G
ENST00000300305.7:c.968C>G
ENST00000344691.8:c.887C>G
ENST00000399240.5:c.695C>G
ENST00000437180.5:c.968C>G
ENST00000482318.5:c.*558C>G
NM_001001890.2:c.887C>G
NM_001754.4:c.968C>G
NM_001001890.3:c.887C>G

Uncertain Significance

Met criteria codes 2
PM2_Supporting BP4
Not Met criteria codes 24
BS2 BS4 BS3 BS1 PVS1 BP7 BP5 BP2 BP3 BP1 PS4 PS2 PS1 PS3 PP1 PP4 PP3 PP2 BA1 PM5 PM1 PM3 PM4 PM6

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.968C>G (p.Thr323Arg) is a missense variant. This variant is absent from both gnomAD v2.1 and gnomAD v3.1.2 (PM2_supporting). This variant has not been reported in any proband meeting at least one of the RUNX1-phenotypic criteria. This missense variant has a REVEL score <0.50 (0.055) (BP4). In summary, this variant meets the criteria to be classified as a variant of uncertain significance. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is absent from both gnomAD v2.1 and gnomAD v3.1.2
BP4
This missense variant has a REVEL score <0.50 (0.055)
Not Met criteria codes
BS2
This rule is not applicable for MM-VCEP
BS4
No case study found
BS3
No functional studies found
BS1
This variant is absent from both gnomAD v2.1 and gnomAD v3.1.2
PVS1
This is not a null variant
BP7
This is not a synonymous variant
BP5
This rule is not applicable for MM-VCEP
BP2
No case study found
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
PS4
No proband meeting RUNX1 phenotypic criteria has been observed
PS2
No case study found
PS1
A missense change in amino acid 323 has not been determined to be pathogenic before
PS3
No functional studies found
PP1
No case study found
PP4
This rule is not applicable for MM-VCEP
PP3
BP4 Met
PP2
This rule is not applicable for MM-VCEP
BA1
This variant is absent from both gnomAD v2.1 and gnomAD v3.1.2
PM5
A missense change in amino acid 323 has not been determined to be pathogenic before
PM1
The variant is located outside of the mutational hot spot and/or critical and well- established functional domain as defined by the MM-VCEP (AA 89-204)
PM3
This rule is not applicable for MM-VCEP
PM4
This is a missense variant
PM6
No case study found
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.